Dr. Goldenberg presents recent studies on various cancers and the implications of new and existing therapies.
You are here
P&T® Journal contents for April 2002
Drug Shortages (4-Part Series)
The results of the ISMP’s recent national survey on drug shortages are discussed, along with guidelines on how to handle drug shortages.
Pharmaceutical Spotlight: Recombinant Human Activated Protein C (rhAPC) or Drotrecogin Alfa (Activated)
This article focuses on the revolutionary new drug that combats a highly complicated disease: sepsis.
Despite the widely held belief that therapy with PPIs renders patients asymptomatic, breakthrough symptoms are common.
Measuring Patients’ Health-Related Quality of Life: Practical Considerations for Implementing an Outcomes Management Program
Patient self-administered questionnaires could help determine health-related quality of life in outcomes management.
Is a placebo-controlled trial ethical if an effective treatment has already been established? The author discusses the issue with Robert Temple, MD.